Literature DB >> 12163606

Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31.

Yijan E Chang1, Loren Pena, Ganes C Sen, Jung K Park, Laimonis A Laimins.   

Abstract

The long-term effects of interferon treatment on cell lines that maintain human papillomavirus type 31 (HPV-31) episomes have been examined. High doses and prolonged interferon treatment resulted in growth arrest of HPV-positive cells, with a high percentage of cells undergoing apoptosis. These effects were not seen with interferon treatment of either normal human keratinocytes or cells derived from HPV-negative squamous carcinomas, which exhibited only slight decreases in their rates of growth. Within 2 weeks of the initiation of treatment, a population of HPV-31-positive cells that were resistant to interferon appeared consistently and reproducibly. The resistant cells had growth and morphological characteristics similar to those of untreated cells. Long-term interferon treatment of HPV-positive cells also resulted in a reduction in HPV episome levels but did not significantly decrease the number of integrated copies of HPV. Cells that maintained HPV genomes lacking E5 were sensitive to interferon, while cells expressing only the E6/E7 genes were resistant. In contrast, cells that expressed E2 from a tetracycline-inducible promoter were found to be significantly more sensitive to interferon treatment than parental cells. This suggests that at least a portion of the sensitivity to interferon could be mediated through the E2 protein. These studies indicate that cells maintaining HPV episomes are highly sensitive to interferon treatment but that resistant populations arise quickly.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163606      PMCID: PMC136980          DOI: 10.1128/jvi.76.17.8864-8874.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 2.  How cells respond to interferons.

Authors:  G R Stark; I M Kerr; B R Williams; R H Silverman; R D Schreiber
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

3.  Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product.

Authors:  B A Spalholz; Y C Yang; P M Howley
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

4.  The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha.

Authors:  P Barnard; N A McMillan
Journal:  Virology       Date:  1999-07-05       Impact factor: 3.616

5.  Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.

Authors:  O Sangfelt; S Erickson; J Castro; T Heiden; A Gustafsson; S Einhorn; D Grandér
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

6.  Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical carcinomas.

Authors:  H Shirasawa; Y Tomita; S Sekiya; H Takamizawa; B Simizu
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

7.  Human fibroblast interferon in cervical and vulvar intraepithelial neoplasia associated with viral cytopathic effects. A pilot study.

Authors:  G De Palo; B Stefanon; F Rilke; S Pilotti; M Ghione
Journal:  J Reprod Med       Date:  1985-05       Impact factor: 0.142

8.  The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.

Authors:  S Li; S Labrecque; M C Gauzzi; A R Cuddihy; A H Wong; S Pellegrini; G J Matlashewski; A E Koromilas
Journal:  Oncogene       Date:  1999-10-14       Impact factor: 9.867

9.  Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes.

Authors:  J T Thomas; W G Hubert; M N Ruesch; L A Laimins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

10.  Induction of multiple programmed cell death pathways by IFN-beta in human non-small-cell lung cancer cell lines.

Authors:  H Zhang; P P Koty; J Mayotte; M L Levitt
Journal:  Exp Cell Res       Date:  1999-02-25       Impact factor: 3.905

View more
  31 in total

1.  The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication.

Authors:  Paramananda Saikia; Volker Fensterl; Ganes C Sen
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 3.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

4.  In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis.

Authors:  Elizabeth Gray; Mark R Pett; Dawn Ward; David M Winder; Margaret A Stanley; Ian Roberts; Cinzia G Scarpini; Nicholas Coleman
Journal:  Cancer Res       Date:  2010-05-04       Impact factor: 12.701

Review 5.  Evasion of host immune defenses by human papillomavirus.

Authors:  Joseph A Westrich; Cody J Warren; Dohun Pyeon
Journal:  Virus Res       Date:  2016-11-24       Impact factor: 3.303

6.  Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response.

Authors:  Mark R Pett; M Trent Herdman; Roger D Palmer; Giles S H Yeo; Mahmud K Shivji; Margaret A Stanley; Nicholas Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

7.  Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins.

Authors:  Christina Habiger; Günter Jäger; Michael Walter; Thomas Iftner; Frank Stubenrauch
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

Review 8.  Human papillomaviruses and the interferon response.

Authors:  Melanie Beglin; Marta Melar-New; Laimonis Laimins
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

9.  Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines.

Authors:  Nadine C Olthof; Christian U Huebbers; Jutta Kolligs; Mieke Henfling; Frans C S Ramaekers; Iris Cornet; Josefa A van Lent-Albrechts; Alexander P A Stegmann; Steffi Silling; Ulrike Wieland; Thomas E Carey; Heather M Walline; Susanne M Gollin; Thomas K Hoffmann; Johan de Winter; Bernd Kremer; Jens P Klussmann; Ernst-Jan M Speel
Journal:  Int J Cancer       Date:  2014-08-14       Impact factor: 7.396

10.  Coordinate regulation of Fanconi anemia gene expression occurs through the Rb/E2F pathway.

Authors:  E E Hoskins; R W Gunawardena; K B Habash; T M Wise-Draper; M Jansen; E S Knudsen; S I Wells
Journal:  Oncogene       Date:  2008-04-28       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.